Buy AbbVie for Reliable Yield and Pipeline Optionality: A 180-Day Trade Plan
AbbVie offers a durable dividend backed by strong free cash flow and a diversified drug portfolio. At $258.38 the stock trades like a mature pharma with growth optionality from immunology and oncology assets. This trade idea lays out an entry at $258.38, stop at $235.00 and a 180-day target of $300.00, with concrete catalysts and downside scenarios…